Using linked birth, notification, hospital and mortality data to examine false-positive meningococcal disease reporting and adjust disease incidence estimates for children in New South Wales, Australia

Author:

GIBSON A.,JORM L.,McINTYRE P.

Abstract

SUMMARYMeningococcal disease is a rare, rapidly progressing condition which may be difficult to diagnose, disproportionally affects children, and has high morbidity and mortality. Accurate incidence estimates are needed to monitor the effectiveness of vaccination and treatment. We used linked notification, hospital, mortality and birth data for all children of an Australian state (2000–2007) to estimate the incidence of meningococcal disease. A total of 595 cases were notified, 684 cases had a hospital diagnosis, and 26 cases died from meningococcal disease. All deaths were notified, but only 68% (466/684) of hospitalized cases. Of non-notified hospitalized cases with more than one clinical admission, most (90%, 103/114) did not have meningococcal disease recorded as their final diagnosis, consistent with initial ‘false-positive’ hospital meningococcal disease diagnosis. After adjusting for false-positive rates in hospital data, capture–recapture estimation suggested that up to four cases of meningococcal disease may not have been captured in either notification or hospital records. The estimated incidence of meningococcal disease in NSW-born and -resident children aged 0–14 years was 5·1–5·4 cases/100 000 child-years at risk, comparable to international estimates using similar methods, but lower than estimates based on hospital data.

Publisher

Cambridge University Press (CUP)

Subject

Infectious Diseases,Epidemiology

Reference31 articles.

1. Invasive meningococcal infection in Western Australia

2. Clinical Excellence Commission. Report of the review of administrative and system issues arising out of two patient deaths attributed to meningococcal disease, 2005, Sydney Hospital & Sydney Eye Hospital: Sydney.

3. Centre for Health Record Linkage. Quality Assurance. 2011 (http://www.cherel.org.au/quality-assurance). Accessed March 2014.

4. Novartis International. Novartis vaccine Bexsero approved in Australia to help protect against MenB disease, a deadly form of bacterial meningitis. 2013 (http://www.novartis.com/newsroom/media-releases/en/2013/1723151.shtml). Accessed December 2013.

5. Underreporting of Meningococcal Disease Incidence in the Netherlands: Results from a Capture–Recapture Analysis Based on Three Registration Sources with Correction for False Positive Diagnoses

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3